HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hideyuki Saya Selected Research

Small Interfering RNA (siRNA)

12/2018Epidermal growth factor receptor promotes glioma progression by regulating xCT and GluN2B-containing N-methyl-d-aspartate-sensitive glutamate receptor signaling.
6/2017Functional analysis of the DEPDC1 oncoantigen in malignant glioma and brain tumor initiating cells.
1/2015Periostin Is a Key Niche Component for Wound Metastasis of Melanoma.
1/2012RNA-binding protein Musashi1 modulates glioma cell growth through the post-transcriptional regulation of Notch and PI3 kinase/Akt signaling pathways.
9/2011Establishment of a choriocarcinoma model from immortalized normal extravillous trophoblast cells transduced with HRASV12.
5/2011Functional analysis of HOXD9 in human gliomas and glioma cancer stem cells.
8/2010Decreased expression of neurofibromin contributes to epithelial-mesenchymal transition in neurofibromatosis type 1.
7/2008Rb depletion results in deregulation of E-cadherin and induction of cellular phenotypic changes that are characteristic of the epithelial-to-mesenchymal transition.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hideyuki Saya Research Topics

Disease

154Neoplasms (Cancer)
04/2024 - 02/2002
24Glioma (Gliomas)
03/2024 - 05/2003
19Glioblastoma (Glioblastoma Multiforme)
03/2024 - 10/2003
19Neoplasm Metastasis (Metastasis)
03/2022 - 02/2007
16Carcinogenesis
10/2021 - 12/2003
13Breast Neoplasms (Breast Cancer)
10/2021 - 07/2008
11Osteosarcoma (Osteogenic Sarcoma)
12/2021 - 08/2007
10Stomach Neoplasms (Stomach Cancer)
12/2023 - 06/2008
9Cholangiocarcinoma
12/2022 - 03/2010
7Brain Neoplasms (Brain Tumor)
01/2019 - 10/2009
6Inflammation (Inflammations)
10/2021 - 09/2013
6Melanoma (Melanoma, Malignant)
06/2021 - 11/2013
6Squamous Cell Carcinoma of Head and Neck
11/2019 - 02/2007
6Neurofibromatosis 1 (Neurofibromatosis Type I)
08/2010 - 03/2003
5Hypoxia (Hypoxemia)
02/2024 - 11/2002
5Carcinoma (Carcinomatosis)
01/2023 - 01/2012
5Warts (Wart)
05/2012 - 10/2002
4Adenocarcinoma
01/2023 - 09/2016
4Prostatic Neoplasms (Prostate Cancer)
01/2023 - 08/2007
4COVID-19
12/2022 - 01/2021
4Astrocytoma (Pilocytic Astrocytoma)
10/2019 - 10/2003
4Leukemia
01/2019 - 10/2009
3Urinary Bladder Neoplasms (Bladder Cancer)
04/2024 - 04/2019
3Esophageal Squamous Cell Carcinoma
06/2023 - 01/2023
3Pancreatic Neoplasms (Pancreatic Cancer)
01/2023 - 04/2005
3Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 11/2013
3Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 01/2016
3Gastrointestinal Neoplasms (Gastrointestinal Cancer)
01/2021 - 03/2011
3Pneumonia (Pneumonitis)
01/2021 - 01/2013
3Fibrosis (Cirrhosis)
05/2018 - 02/2010
3Metaplasia
02/2017 - 10/2013
3Retinoblastoma (Glioblastoma, Retinal)
06/2012 - 11/2006
2Ascites
12/2023 - 01/2022
2Infections
06/2023 - 12/2022

Drug/Important Bio-Agent (IBA)

22Proteins (Proteins, Gene)FDA Link
12/2022 - 07/2003
15Phosphotransferases (Kinase)IBA
10/2021 - 12/2003
14Sulfasalazine (Azulfidine)FDA LinkGeneric
03/2021 - 10/2013
13Protein Isoforms (Isoforms)IBA
07/2022 - 01/2012
12Glutathione (Reduced Glutathione)IBA
01/2020 - 01/2012
12Cystine (L-Cystine)IBA
11/2019 - 06/2012
10Biomarkers (Surrogate Marker)IBA
04/2024 - 05/2016
10EnzymesIBA
01/2023 - 01/2005
10DNA (Deoxyribonucleic Acid)IBA
05/2022 - 05/2002
10Cisplatin (Platino)FDA LinkGeneric
03/2021 - 01/2016
10Glutamic Acid (Glutamate)FDA Link
11/2019 - 04/2015
9Reactive Oxygen Species (Oxygen Radicals)IBA
11/2017 - 03/2011
8AntioxidantsIBA
01/2021 - 03/2012
8Small Interfering RNA (siRNA)IBA
12/2018 - 07/2008
8ErbB Receptors (EGF Receptor)IBA
12/2018 - 10/2003
7Transcription Factors (Transcription Factor)IBA
01/2021 - 08/2010
7Cadherins (E-Cadherin)IBA
01/2021 - 07/2008
7Messenger RNA (mRNA)IBA
01/2020 - 03/2010
6LigandsIBA
10/2021 - 01/2014
6Neurofibromin 1 (Neurofibromin)IBA
01/2018 - 07/2003
5Epithelial Cell Adhesion MoleculeIBA
12/2023 - 11/2011
5Glucose (Dextrose)FDA LinkGeneric
01/2022 - 03/2012
5Paclitaxel (Taxol)FDA LinkGeneric
01/2018 - 02/2002
5Hyaluronic Acid (Hyaluronan)IBA
01/2017 - 08/2003
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2015 - 06/2008
5Cyclin-Dependent Kinase Inhibitor p16IBA
06/2012 - 11/2006
4Antineoplastic Agents (Antineoplastics)IBA
04/2024 - 08/2004
4AntibodiesIBA
06/2023 - 01/2016
4Amino AcidsFDA Link
01/2023 - 10/2012
4CytokinesIBA
10/2021 - 05/2009
4Celecoxib (Celebrex)FDA Link
01/2021 - 01/2017
4AntiportersIBA
11/2019 - 09/2018
4Trastuzumab (Herceptin)FDA Link
01/2018 - 05/2008
4Monoclonal AntibodiesIBA
01/2016 - 08/2003
3Circulating Tumor DNAIBA
06/2023 - 01/2023
3GemcitabineFDA Link
01/2023 - 03/2021
3RNA (Ribonucleic Acid)IBA
01/2023 - 01/2017
3Neutralizing AntibodiesIBA
12/2022 - 01/2021
3Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
03/2022 - 12/2017
3Oxygen (Dioxygen)IBA
01/2022 - 01/2018
3PeriostinIBA
06/2021 - 01/2015
3Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
01/2021 - 01/2017
3LipidsIBA
01/2021 - 10/2012
3MicellesIBA
10/2019 - 01/2016
3Histones (Histone)IBA
01/2019 - 05/2013
3Epidermal Growth Factor (EGF)IBA
12/2018 - 01/2014
3human ERBB2 proteinIBA
07/2018 - 06/2012
3Indicators and Reagents (Reagents)IBA
01/2018 - 05/2016
3spasmolytic polypeptideIBA
02/2017 - 10/2013
3Dinoprostone (PGE2)FDA Link
03/2016 - 03/2010
3Progesterone Receptors (Progesterone Receptor)IBA
12/2015 - 06/2012
3Estrogen ReceptorsIBA
12/2015 - 06/2012
3Pyruvate KinaseIBA
08/2014 - 03/2012
3GTPase-Activating Proteins (GTPase-Activating Protein)IBA
11/2005 - 07/2003
3Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
08/2005 - 10/2002
2protoporphyrin IXIBA
03/2024 - 01/2021
2Androgen Receptors (Androgen Receptor)IBA
10/2023 - 08/2007
2BoronIBA
01/2023 - 01/2012

Therapy/Procedure

40Therapeutics
04/2024 - 05/2003
20Drug Therapy (Chemotherapy)
02/2024 - 07/2009
6Transplantation
03/2022 - 02/2010
5Radiotherapy
01/2023 - 01/2016
4Aftercare (After-Treatment)
01/2016 - 04/2005
3Immunotherapy
04/2023 - 01/2018
2Neoadjuvant Therapy
02/2024 - 06/2023
2Castration
01/2023 - 05/2016